PT93170A - Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo - Google Patents
Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activoInfo
- Publication number
- PT93170A PT93170A PT93170A PT9317090A PT93170A PT 93170 A PT93170 A PT 93170A PT 93170 A PT93170 A PT 93170A PT 9317090 A PT9317090 A PT 9317090A PT 93170 A PT93170 A PT 93170A
- Authority
- PT
- Portugal
- Prior art keywords
- active ingredient
- capsules containing
- distribution devices
- piece
- preparing distribution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
- Formation And Processing Of Food Products (AREA)
- Sampling And Sample Adjustment (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Massaging Devices (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Molding Of Porous Articles (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Eye Examination Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898903566A GB8903566D0 (en) | 1989-02-16 | 1989-02-16 | Drug dispensing device |
GB898921155A GB8921155D0 (en) | 1989-09-19 | 1989-09-19 | Drug dispensing device |
Publications (2)
Publication Number | Publication Date |
---|---|
PT93170A true PT93170A (pt) | 1990-08-31 |
PT93170B PT93170B (pt) | 1996-12-31 |
Family
ID=26294964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT93170A PT93170B (pt) | 1989-02-16 | 1990-02-15 | Processo para a preparacao de dispositivos distribuidores nomeadamente, de capsulas contendo um ingrediente activo |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP0458887A1 (pt) |
JP (1) | JPH0818971B2 (pt) |
KR (1) | KR0141473B1 (pt) |
AT (1) | ATE90202T1 (pt) |
AU (1) | AU629915B2 (pt) |
CA (1) | CA2047738C (pt) |
DE (1) | DE69001831T2 (pt) |
DK (1) | DK0384646T3 (pt) |
ES (1) | ES2043270T3 (pt) |
FI (1) | FI913880A0 (pt) |
GB (1) | GB2230442B (pt) |
HU (1) | HU207940B (pt) |
IE (1) | IE64761B1 (pt) |
NO (1) | NO303618B1 (pt) |
NZ (1) | NZ232561A (pt) |
PT (1) | PT93170B (pt) |
RU (1) | RU2104084C1 (pt) |
WO (1) | WO1990009168A1 (pt) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
GB9004702D0 (en) * | 1990-03-02 | 1990-04-25 | Polysystems Limited | Dispensing device |
US5474784A (en) * | 1990-03-02 | 1995-12-12 | British Technology Group Limited | Dispensing device |
AU651654B2 (en) * | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
US5266325A (en) * | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
AU652984B2 (en) * | 1992-01-14 | 1994-09-15 | Endo Pharmaceuticals Solutions Inc. | Preparation of homogeneous hydrogel copolymers |
GB9223144D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Controlled release device |
GB9223172D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule construction |
GB9223146D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Vented capsule |
GB9223148D0 (en) * | 1992-11-05 | 1992-12-16 | Scherer Corp R P | Capsule cap |
CZ286051B6 (cs) * | 1993-02-26 | 1999-12-15 | The Procter & Gamble Company | Farmaceutický prostředek a způsob jeho použití pro dasažení projímavého účinku |
EP0695174B1 (en) * | 1993-04-20 | 2003-03-19 | TSRL, Inc. | Multi-stage drug delivery system |
GB9320732D0 (en) * | 1993-10-08 | 1993-12-01 | Scherer Corp R P | Controlled delivery of liquid |
GB9320733D0 (en) * | 1993-10-08 | 1993-12-01 | Scherer Corp R P | Controlled release device construction |
EP0724441A1 (en) * | 1993-10-19 | 1996-08-07 | The Procter & Gamble Company | Picosulphate dosage form |
GB9323261D0 (en) * | 1993-11-11 | 1994-01-05 | Scherer Corp R P | Dispensing device |
US5516524A (en) * | 1993-12-20 | 1996-05-14 | The Procter & Gamble Company | Laxative compositions containing bulk fiber |
JP2977907B2 (ja) * | 1994-05-06 | 1999-11-15 | ファイザー・インコーポレーテッド | アジスロマイシンの放出調節された剤形 |
GB9718664D0 (en) | 1997-09-04 | 1997-11-05 | Scherer Corp R P | Improvements in or relating to capsules |
GB9724450D0 (en) * | 1997-11-20 | 1998-01-14 | Scherer Corp R P | Delayed release device |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
CN1296417A (zh) | 1998-02-10 | 2001-05-23 | 卫福有限公司 | 控释制剂 |
US20010055613A1 (en) | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
FR2843302B1 (fr) | 2002-08-09 | 2004-10-22 | Centre Nat Rech Scient | Forme galenique pour la delivrance colique de principes actifs |
US6913768B2 (en) | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
CA2570960C (en) | 2004-06-17 | 2013-10-01 | Valera Pharmaceuticals, Inc. | Compositions and methods for treating central precocious puberty |
EP1888043A4 (en) | 2005-03-11 | 2010-07-28 | Endo Pharmaceuticals Solutions | OCTREOTIDE FORMULATIONS WITH CONTROLLED RELEASE |
EP1916995B2 (en) | 2005-07-29 | 2022-06-29 | Stichting Groningen Centre for Drug Research | Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
AU2006318349B2 (en) | 2005-11-28 | 2010-08-19 | Marinus Pharmaceuticals | Ganaxolone formulations and methods for the making and use thereof |
CA2634139C (en) | 2005-12-20 | 2015-06-23 | Cenestra, Llc. | Omega 3 fatty acid formulations |
EP2428205B1 (en) | 2006-03-16 | 2012-10-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
WO2008062320A2 (en) | 2006-10-06 | 2008-05-29 | Eisai R&D Management Co., Ltd | Extended release formulations of a proton pump inhibitor |
NZ580803A (en) | 2007-04-27 | 2012-03-30 | Endo Pharmaceuticals Solutions | Implant device release agents and methods of using same |
JP5622725B2 (ja) | 2008-06-25 | 2014-11-12 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. | エキセナチド及び他のポリペプチド類の持続的送達 |
AU2009262263B2 (en) | 2008-06-25 | 2014-08-14 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
US20110311628A1 (en) | 2009-03-09 | 2011-12-22 | Council Of Scientific And Industrial Research | Pulsatile release composition of therapeutic agent |
US9731025B2 (en) | 2010-08-20 | 2017-08-15 | National University Corporation Tokyo Medical And Dental University | Pharmaceutical composition for transcolonic absorption |
US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
EP3272342B1 (en) | 2011-03-23 | 2021-05-26 | Ironshore Pharmaceuticals & Development, Inc. | Methods and compositions for treatment of attention deficit disorder |
US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
DK2739270T3 (da) * | 2011-08-01 | 2020-04-06 | Hb Biotechnologies Corp | Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer |
JP2015506359A (ja) * | 2012-01-04 | 2015-03-02 | ウェルズリー ファーマスーティカルズ、エルエルシー | 排尿頻度を減少させるための遅延放出製剤およびその使用の方法 |
US10278925B2 (en) | 2012-01-04 | 2019-05-07 | Wellesley Pharmaceuticals, Llc | Delayed-release formulations, methods of making and use thereof |
MY189576A (en) | 2012-03-30 | 2022-02-17 | Micelle Biopharma Inc | Omega-3 fatty acid ester compositions |
CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
AU2014373683B2 (en) | 2013-12-31 | 2020-05-07 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
EP3131546B1 (en) | 2014-04-16 | 2022-02-16 | Rapamycin Holdings, Inc. | Oral rapamycin preparation for use in treating feline chronic gingivo- stomatitis (fcgs) |
KR20240039186A (ko) | 2015-06-03 | 2024-03-26 | 트리아스텍 인코포레이티드 | 제형 및 이의 용도 |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
EP3452003A4 (en) * | 2016-05-05 | 2019-06-26 | Triastek, Inc. | PHARMACEUTICAL FORM WITH CONTROLLED RELEASE |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
CN111698983B (zh) | 2018-01-09 | 2022-10-18 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非***和adhd***的复方口服药物剂型 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB436236A (en) * | 1934-04-26 | 1935-10-08 | Karl Wilhelm Schmidt | Improvements in and relating to a therapeutic capsule |
US3952741A (en) * | 1975-01-09 | 1976-04-27 | Bend Research Inc. | Controlled release delivery system by an osmotic bursting mechanism |
GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
GB8403138D0 (en) * | 1984-02-07 | 1984-03-14 | Graham N B | Sustained release of active ingredient |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
-
1990
- 1990-02-15 ES ES90301617T patent/ES2043270T3/es not_active Expired - Lifetime
- 1990-02-15 WO PCT/GB1990/000248 patent/WO1990009168A1/en not_active Application Discontinuation
- 1990-02-15 AT AT90301617T patent/ATE90202T1/de not_active IP Right Cessation
- 1990-02-15 RU SU5001579A patent/RU2104084C1/ru active
- 1990-02-15 JP JP2503924A patent/JPH0818971B2/ja not_active Expired - Lifetime
- 1990-02-15 AU AU51632/90A patent/AU629915B2/en not_active Ceased
- 1990-02-15 EP EP90903866A patent/EP0458887A1/en active Pending
- 1990-02-15 DE DE9090301617T patent/DE69001831T2/de not_active Expired - Fee Related
- 1990-02-15 CA CA002047738A patent/CA2047738C/en not_active Expired - Fee Related
- 1990-02-15 GB GB9003503A patent/GB2230442B/en not_active Expired - Lifetime
- 1990-02-15 IE IE55690A patent/IE64761B1/en not_active IP Right Cessation
- 1990-02-15 PT PT93170A patent/PT93170B/pt not_active IP Right Cessation
- 1990-02-15 EP EP90301617A patent/EP0384646B1/en not_active Expired - Lifetime
- 1990-02-15 HU HU902238A patent/HU207940B/hu not_active IP Right Cessation
- 1990-02-15 DK DK90301617.8T patent/DK0384646T3/da active
- 1990-02-16 NZ NZ232561A patent/NZ232561A/en unknown
-
1991
- 1991-08-08 NO NO913081A patent/NO303618B1/no unknown
- 1991-08-16 FI FI913880A patent/FI913880A0/fi unknown
- 1991-08-16 KR KR91700909A patent/KR0141473B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO913081D0 (no) | 1991-08-08 |
JPH0818971B2 (ja) | 1996-02-28 |
PT93170B (pt) | 1996-12-31 |
NZ232561A (en) | 1992-02-25 |
WO1990009168A1 (en) | 1990-08-23 |
JPH04505004A (ja) | 1992-09-03 |
ES2043270T3 (es) | 1993-12-16 |
FI913880A0 (fi) | 1991-08-16 |
GB2230442B (en) | 1992-11-25 |
NO913081L (no) | 1991-08-08 |
EP0384646B1 (en) | 1993-06-09 |
KR920700617A (ko) | 1992-08-10 |
DK0384646T3 (da) | 1993-07-12 |
HU207940B (en) | 1993-07-28 |
ATE90202T1 (de) | 1993-06-15 |
HUT58509A (en) | 1992-03-30 |
GB2230442A (en) | 1990-10-24 |
EP0384646A1 (en) | 1990-08-29 |
IE900556L (en) | 1990-08-16 |
CA2047738C (en) | 2000-02-15 |
IE64761B1 (en) | 1995-09-06 |
RU2104084C1 (ru) | 1998-02-10 |
CA2047738A1 (en) | 1990-08-17 |
KR0141473B1 (en) | 1998-06-01 |
GB9003503D0 (en) | 1990-04-11 |
AU629915B2 (en) | 1992-10-15 |
EP0458887A1 (en) | 1991-12-04 |
AU5163290A (en) | 1990-09-05 |
NO303618B1 (no) | 1998-08-10 |
HU902238D0 (en) | 1991-11-28 |
DE69001831D1 (de) | 1993-07-15 |
DE69001831T2 (de) | 1993-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT93170A (pt) | Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo um ingrediente activo | |
ES2010648T3 (es) | Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral. | |
ES2006457A4 (es) | Un procedimiento para la preparacion de una formulacion farmaceutica. | |
NO163356C (no) | Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament. | |
NO20005431D0 (no) | Gelérbare farmasøytiske preparater | |
DK74187D0 (da) | Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf | |
DE58906926D1 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung. | |
ES2080796T5 (es) | Formulaciones de productos farmaceuticos de liberacion prolongada. | |
AU1810783A (en) | Constant release tablet formulation | |
DE58901990D1 (de) | Feste pharmazeutische retardform. | |
PT93168A (pt) | Processo para a preparacao de dispositivos distribuidores nomeadamente de capsulas contendo ingredientes activos | |
DE58902457D1 (de) | Retardierte arzneiform und verfahren zu ihrer herstellung. | |
ES2059495T3 (es) | Dispositivo de descarga de farmacos regulado por solubilidad. | |
ES2190819T3 (es) | Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones. | |
MX5953E (es) | Procedimiento mejorado para la produccion de pildoras para la liberacion controlada de productos quimicos biologicamente activos | |
AR004004A1 (es) | Benzoilguanidinas sustituida, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento quelas contiene. | |
ES2053528T3 (es) | Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua. | |
JPS5282715A (en) | Long acting drug composition | |
DE69416034D1 (de) | Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen | |
TH6020B (th) | สูตรผสมเมนาไดโอนไบซัลโฟท์ที่ได้ทำให้เสถียร และการเตรียมสูตรผสมเหล่านี้ | |
JPS54128575A (en) | Novel pentalenonelactone compound and drugs comprising it as active constituent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19960903 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20040331 |